Corbus Pharmaceuticals (CRBP)
(Delayed Data from NSDQ)
$37.45 USD
-1.80 (-4.57%)
Updated Apr 22, 2024 11:53 AM ET
After-Market: $37.70 +0.26 (0.68%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-1.09 | 0.00% |
Earnings Summary
For their last quarter, Corbus Pharmaceuticals (CRBP) reported earnings of -$1.81 per share, beating the Zacks Consensus Estimate of $-2.36 per share. This reflects a positive earnings surprise of 23.31%. Look out for CRBP's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$1.09 per share, reflecting a year-over-year increase of 74.29%.
Earnings History
Price & Consensus
Zacks News for CRBP
What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'
CRBP: What are Zacks experts saying now?
Zacks Private Portfolio Services